EP3501542
ESKETAMÍN TIL MEÐFERÐAR VIÐ ÞUNGLYNDI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.12.2018EP published:
28.1.2026EP application number:
18215651.3
EP translation filed:
16.4.2026Grant published:
13.5.2026EPO information:
European Patent Register
Max expiry date:
20.12.2038Expiry date:
20.12.2026
Title in English:
ESKETAMINE FOR THE TREATMENT OF DEPRESSIONLanguage of the patent:
English
Timeline
Today
21.12.2018EP application
28.1.2026EP Publication
16.4.2026Translation submitted
13.5.2026Registration published
20.12.2026Expires
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
CANUSO, CarlaAddress:
Titusville, NJ New Jersey 08560, US
Name:
DALY, EllaAddress:
Titusville, NJ New Jersey 08560, US
Name:
DREVETS, WayneAddress:
San Diego, CA California 92121, US
Name:
LI, HonglanAddress:
Pennington, NJ New Jersey 08534, US
Name:
HOUGH, David WoodAddress:
Pennington, NJ New Jersey 08534, US
Name:
JANIK, AdamAddress:
San Diego, CA California 92121, US
Name:
OCHS-ROSS, RachelAddress:
Pennington, NJ New Jersey 08534, US
Name:
SINGH, JaskaranAddress:
San Diego, CA California 92121, US
Name:
WAJS, EwaAddress:
2340 Beerse, BE
Name:
ZANNIKOS, PeterAddress:
Titusville, NJ New Jersey 08560, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201762609504 PDate:
22.12.2017Country:
US
Number:
201862663219 PDate:
26.4.2018Country:
US
Number:
201862663206 PDate:
26.4.2018Country:
US
Number:
201862667406 PDate:
4.5.2018Country:
US
Number:
201862675846 PDate:
24.5.2018Country:
US
Number:
201862755905 PDate:
5.11.2018Country:
US
Classification
Categories:
A61K 31/135, A61K 45/06, A61P 25/24